YWYangdi Wang

Yangdi Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yangdi Wang has a total of 59 co-authors. Here are the top co-authors by number of shared publications:

  • Lili Huang

    Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China

    4 shared publications
  • Qingzhu Zheng

    Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, 58 Zhongshan 2nd Rd, Guangzhou 510080, People’s Republic of China

    3 shared publications
  • Ren Mao

    Department of Gastroenterology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China

    3 shared publications
  • Xinyue Wang

    Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China

    3 shared publications
  • Zhenpeng Peng

    Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    3 shared publications
  • Jiaxin Yuan

    Department of Radiology, the First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

    2 shared publications

Latest Publications

  • MR Elastography Characterization of Biomechanical Properties to Enhance Enterographic Fibrosis Diagnosis

    by Zhihui Chen, Yangdi Wang, Zhuangnian Fang, Mengchen Zhang, Ruonan Zhang, Qingzhu Zheng, Lili Huang, Luyao Wu, Yaoqi Ke, Qiaochu Zhao, et al.

    In participants with Crohn disease, MR elastography quantified tissue biomechanics, and incorporation of MR elastography improved the diagnostic performance of MR enterography for intestinal fibrosis stratification in Crohn disease.


  • Dual-layer spectral detector CT: a non-invasive tool for simultaneously predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma

    by Jiaxin Yuan, Jiawei Liu, Mingjie Chen, Yangdi Wang, Minghao Zhang, Liqin Wang, Zhenpeng Peng, Luyong Wei, Siya Shi, Yanji Luo

    Objectives To evaluate the value of dual-layer spectral detector CT (DLCT) for predicting Ki-67 proliferation status and p53 mutations in pancreatic ductal adenocarcinoma (PDAC). Materials & methods This retrospective study included untreated patients with pathologically confirmed PDAC who underwent DLCT between June 2019 and September 2023. Independent relevant clinical-radiological features and quantitative parameters for predicting Ki-67 proliferation status and p53 mutations were identified using multivariate logistic regression analysis. The diagnostic performances of independent variables were evaluated using receiver operating characteristic curves. Results We included 92 patients (60.19 ± 11.22 years old, 61 males). There were 40 patients with high Ki-67 expression (Ki-67 ≥ 25%) and 43 patients positive for p53 mutation. The radiologists showed substantial or near-perfect inter- and intra-observer agreement in evaluating quantitative parameters. Normalised iodine concentration in the arterial phase (nICa) was the only independent predictor of Ki-67 proliferation status (p < 0.001; adjusted odds ratio [OR], 2.33; 95% confidence interval [CI]: 1.46, 3.74; cut-off, 0.0910) and p53 mutations (p < 0.001; adjusted OR, 1.35; 95% CI: 1.07, 1.71; cut-off, 0.0905) according to the multivariate logistic analysis. nICa showed satisfactory performance when using the chosen rounded cut-off value of 0.090 (easily applicable in clinical practice) in predicting Ki-67 proliferation (area under the receiver operating characteristic curve [AUC], 0.812; sensitivity, 87.5%; specificity, 75.0%) and p53 mutations (AUC, 0.731; sensitivity, 76.7%; specificity, 69.4%). Conclusion The DLCT parameter nICa enables simultaneous and non-invasive prediction of both Ki-67 proliferation status and p53 mutations in PDAC with satisfactory diagnostic efficacy.


  • Open Access

    Intestinal fibrosis assessment in Crohn’s disease patient using unenhanced spectral CT combined with 3D-printing technique

    by Qiapeng Huang, Zhihui Chen, Ruonan Zhang, Huasong Cai, Xufeng Yang, Xiaodi Shen, Lili Huang, Xinyue Wang, Qingzhu Zheng, Mingzhe Li, et al.

    Objectives: To integrate multiple parameters derived from unenhanced spectral CT with 3D-printing technique to accurately evaluate intestinal lesions in patients with Crohn’s disease (CD). Methods: Patients with proven CD who underwent preoperative spectral CT and surgery were included. The spectral CT images and histopathological specimens were achieved by employing 3D-printing technique. Diagnostic models were developed utilizing Z-Effective, Electron Density (ED), and Hounsfield unit (HU) values derived from spectral CT, along with spectral curve slopes λ1 and λ2, as well as ΔHUMonoE. The area under the receiver operating characteristic curve (AUC) and the influence of inflammation on the efficacy of the models were analyzed. Results: The ED and HU at MonoE 50 keV of the spectral CT were determined to exhibit the highest correlation with the fibrosis degree of the diseased intestine. The training dataset yielded an AUC of 0.828 (95% CI: 0.705–0.951). The sensitivity and specificity were calculated to be 77.3% and 82.6%, respectively. The AUC of the validation set was 0.812 (95% CI: 0.676–0.948) with a sensitivity of 63.6% and specificity of 89.7%. Moreover, our model demonstrated enhanced diagnostic accuracy for detecting fibrosis with an AUC value of 0.933 (95% CI: 0.856–1.000), sensitivity of 90.9%, and specificity of 87.0%, after regulating the influence of inflammation. Conclusion: The integration of unenhanced multi-parametric spectral CT and 3D-printing technique seems to be able to assess the intestinal fibrosis. Our diagnostic model remains effective in assessing the severity of fibrosis under presence of inflammation. Critical relevance statement: Our diagnostic model accurately assessed the degree of intestinal wall fibrosis in Crohn’s disease patients by using unenhanced spectral CT and 3D-printing technique, which could facilitate individualized treatment. Key Points: Evaluating the extent of Crohn’s disease-related fibrosis is important. The combination of 3D-printing technique and multi-parametric spectral CT enhances diagnostic accuracy. The developed model using spectral CT allows for the assessment of intestinal fibrosis using multi-parameters. Graphical


  • Open Access

    Multiomics reveals microbial metabolites as key actors in intestinal fibrosis in Crohn’s disease

    by Xuehua Li, Shixian Hu, Xiaodi Shen, Ruonan Zhang, Caiguang Liu, Lin Xiao, Jinjiang Lin, Li Huang, Weitao He, Xinyue Wang, et al.

    Intestinal fibrosis is the primary cause of disability in patients with Crohn’s disease (CD), yet effective therapeutic strategies are currently lacking. Here, we report a multiomics analysis of gut microbiota and fecal/blood metabolites of 278 CD patients and 28 healthy controls, identifying characteristic alterations in gut microbiota (e.g., Lachnospiraceae , Ruminococcaceae , Muribaculaceae , Saccharimonadales ) and metabolites (e.g., L -aspartic acid, glutamine, ethylmethylacetic acid) in moderate-severe intestinal fibrosis. By integrating multiomics data with magnetic resonance enterography features, putative links between microbial metabolites and intestinal fibrosis-associated morphological alterations were established. These potential associations were mediated by specific combinations of amino acids (e.g., L -aspartic acid), primary bile acids, and glutamine. Finally, we provided causal evidence that L -aspartic acid aggravated intestinal fibrosis both in vitro and in vivo. Overall, we offer a biologically plausible explanation for the hypothesis that gut microbiota and its metabolites promote intestinal fibrosis in CD while also identifying potential targets for therapeutic trials.


  • A novel multidisciplinary machine learning approach based on clinical, imaging, colonoscopy, and pathology features for distinguishing intestinal tuberculosis from Crohn’s disease

    by Baolan Lu, Zengan Huang, Jinjiang Lin, Ruonan Zhang, Xiaodi Shen, Lili Huang, Xinyue Wang, Weitao He, Qiapeng Huang, Jiayu Fang, et al.

    Objectives Differentiating intestinal tuberculosis (ITB) from Crohn’s disease (CD) remains a diagnostic dilemma. Misdiagnosis carries potential grave implications. We aim to establish a multidisciplinary-based model using machine learning approach for distinguishing ITB from CD. Methods Eighty-two patients including 25 patients with ITB and 57 patients with CD were retrospectively recruited (54 in training cohort and 28 in testing cohort). The region of interest (ROI) for the lesion was delineated on magnetic resonance enterography (MRE) and colonoscopy images. Radiomic features were extracted by least absolute shrinkage and selection operator regression. Pathological feature was extracted automatically by deep-learning method. Clinical features were filtered by logistic regression analysis. Diagnostic performance was evaluated by receiver operating characteristic (ROC) curve and decision curve analysis (DCA). Delong’s test was applied to compare the efficiency between the multidisciplinary-based model and the other four single-disciplinary-based models. Results The radiomics model based on MRE features yielded an AUC of 0.87 (95% confidence interval [CI] 0.68–0.96) on the test data set, which was similar to the clinical model (AUC, 0.90 [95% CI 0.71–0.98]) and higher than the colonoscopy radiomics model (AUC, 0.68 [95% CI 0.48–0.84]) and pathology deep-learning model (AUC, 0.70 [95% CI 0.49–0.85]). Multidisciplinary model, integrating 3 clinical, 21 MRE radiomic, 5 colonoscopy radiomic, and 4 pathology deep-learning features, could significantly improve the diagnostic performance (AUC of 0.94, 95% CI 0.78–1.00) on the bases of single-disciplinary-based models. DCA confirmed the clinical utility. Conclusions Multidisciplinary-based model integrating clinical, MRE, colonoscopy, and pathology features was useful in distinguishing ITB from CD. Graphical Abstract


  • Dual-energy CT improves differentiation of non-hypervascular pancreatic neuroendocrine neoplasms from CA 19-9-negative pancreatic ductal adenocarcinomas

    by Xuefang Hu, Siya Shi, Yangdi Wang, Jiaxin Yuan, Mingjie Chen, Luyong Wei, Weiwei Deng, Shi-Ting Feng, Zhenpeng Peng, Yanji Luo

    Purpose To evaluate the utility of dual-energy CT (DECT) in differentiating non-hypervascular pancreatic neuroendocrine neoplasms (PNENs) from pancreatic ductal adenocarcinomas (PDACs) with negative carbohydrate antigen 19–9 (CA 19-9). Methods This retrospective study included 26 and 39 patients with pathologically confirmed non-hypervascular PNENs and CA 19-9-negative PDACs, respectively, who underwent contrast-enhanced DECT before treatment between June 2019 and December 2021. The clinical, conventional CT qualitative, conventional CT quantitative, and DECT quantitative parameters of the two groups were compared using univariate analysis and selected by least absolute shrinkage and selection operator regression (LASSO) analysis. Multivariate logistic regression analyses were performed to build qualitative, conventional CT quantitative, DECT quantitative, and comprehensive models. The areas under the receiver operating characteristic curve (AUCs) of the models were compared using DeLong’s test. Results The AUCs of the DECT quantitative (based on normalized iodine concentrations [nICs] in the arterial and portal venous phases: 0.918; 95% confidence interval [CI] 0.852–0.985) and comprehensive (based on tumour location and nICs in the arterial and portal venous phases: 0.966; 95% CI 0.889–0.995) models were higher than those of the qualitative (based on tumour location: 0.782; 95% CI 0.665–0.899) and conventional CT quantitative (based on normalized conventional CT attenuation in the arterial phase: 0.665; 95% CI 0.533–0.797; all P < 0.05) models. The DECT quantitative and comprehensive models had comparable performances (P = 0.076). Conclusions Higher nICs in the arterial and portal venous phases were associated with higher blood supply improving the identification of non-hypervascular PNENs.